CTSI Update: Application Deadline

Don't miss the deadline for the K Grant Writing Workshop,
it is open to Faculty and accomplished Post-doctoral Students/Fellows who will be remaining at BUMC.
New Funding Opportunities

SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional)


Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)

National Cancer Institute ( NCI )
Availability of
Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19 in Individuals with Down Syndrome for the INCLUDE Project

National Human Genome Research Institute ( NHGRI )

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)

National Institute of Mental Health ( NIMH )


Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)

National Institute on Minority Health and Health Disparities ( NIMHD )
News Highlights
Seeing Coronavirus Replicate in Kidney Cells
The image depicts a common primate kidney cell line (green) infected with SARS-CoV-2. Notice the bulging, spherical cellular blebs, seen best in the upper right corner. These badly damaged cells, which are filled to the point of bursting with viral particles, are beginning to self-destruct.
 
CO vid-19  P articipant  E xperience (COPE) Survey
All of Us invites you to take part in a new
survey about how COVID-19 is affecting you
and your community. It’s called the  CO vid 19  P articipant  E xperience, or COPE, survey.

N3C: Partnership and Governance for
COVID-19 Research
The National COVID Cohort Collaborative (N3C) was assembled to answer questions and meet emerging research needs brought to light by the novel coronavirus.

NIH ACTIV Vaccine Working Group Weighs Role of Human Challenge Studies for SARS-CoV-2 Vaccine Development
Members of the NIH's Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Vaccines Working Group assess practical considerations and prerequisites for using controlled human infection models (CHIMs), which can be used to support SARS-CoV-2 vaccine development.

Upcoming Events
Current Trends in Qualitative Methodology for Translational Science Research and Evaluation- July 08, 2020 - 11:00 a.m. ET 

The purpose of this panel is to demonstrate the application of current qualitative methods to evaluate clinical and translational science programs, organizations, and enterprises.


COVID Open Science Collaborative Analytics Platform: National COVID Cohort Collaborative (N3C)- July 10, 2020 - 04:00 p.m. ET

Join the Ground Rounds Rethinking Clinical Trial Series.


CD2H Biobank National Network Virtual Tools Webinar - July 15, 2020 - 1:00 p.m. ET 

This webinar is about the sharing of data for biospecimens and their phenotypes.

Challenges in Brain Analytics and Integration -
Application Deadline: July 24, 2020, 11:59 p.m. ET

A hybrid event with four virtual microlabs and a five-day residential workshop focused on neuroscientific analytics and integration for quantitative and biomedical researchers.

Call for Participation for AMIA 2021 Informatics Summit -
Submission Deadline: August 13, 2020, 11:59 p.m. ET

The Summit is a conference that gives a voice to informaticians from four key constituencies who are working to improve healthcare. Attendees will experience content dedicated to Bioinformatics, Clinical Research Informatics, Informatics Implementation, and Data Science in one integrated conference experience.

Boston University Clinical & Translational Science Institute
Accelerating Discoveries Towards Better Health 
b u.edu/ctsi | ncats.nih.gov